The effects of oral administration of aureomycin, sulfathiazole, sulfamerazine and 4,4'-diamino diphenyl sulfone on toxoplasmosis in mice.
SUMMERS
W A
WA
D000284:Administration, Oral; D000818:Animals; D001713:Biphenyl Compounds; D002751:Chlortetracycline; D051379:Mice; D013416:Sulfamerazine; D000077145:Sulfanilamide; D013424:Sulfanilamides; D000077589:Sulfathiazole; D013432:Sulfathiazoles; D013449:Sulfonamides; D013450:Sulfones; D014123:Toxoplasmosis
D001713:Biphenyl Compounds; D002751:Chlortetracycline; D013416:Sulfamerazine; D000077145:Sulfanilamide; D013424:Sulfanilamides; D000077589:Sulfathiazole; D013432:Sulfathiazoles; D013449:Sulfonamides; D013450:Sulfones; C010574:biphenyl